The process of T-cell development depends upon both positive and negative selection to produce a population of T-cells that are reactive with foreign, but not self peptides in association with self-encoded MHC molecules. Experiments are proposed to characterize the signal transduction pathways that contribute to or determine the fate of developing thymocytes: either apoptotic death, or differentiation into CD4 or CD8 positive T-cells.
In Aim 1 experiments are proposed to determine how the MAP kinase-related molecules, Erk, JNK, and p38 affect positive and negative selection. Transgenic mice will be produced that express either constitutive or inducible forms of signaling intermediates which cause induction and nuclear translocation of one of these three serine/threonine kinases. The analysis will determine the quantitative effects on both positive and negative selection, and the differential effects on maturation into either CD4 or CD8 positive T-cells. Biochemical analyses will determine the basal level and inducible activity of the parallel Map Kinase pathways.
In Aim 2 the observation that a dominant interfering form of an atypical PKC can enhance negative selection will be investigated. The effects of this mutation on intermediates in the Ras-Erk pathway will be investigated. In addition mice with a targeted deletion in the gene encoding this molecule will be produced and the effects of this deletion on thymocyte development will be determined.
In Aim 3 the role of a calcium-calmodulin induced phosphatase, calcineurin, and kinase, CamKIIg will be investigated. Calcium-independent form of calcineurin can affect the efficiency of positive selection. the effect of this transgene on positive and negative selection, and on the activation of downstream effector molecules, such as members of the NF-AT family will be characterized. Thymic development is one of the most carefully studied models of cellular differentiation in a mammalian organism and, as such, it is important not only in understanding the function and selection of the immune system, but also as a model for cellular differentiation.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Experimental Immunology Study Section (EI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California San Diego
La Jolla
United States
Zip Code
Mingueneau, Michael; Krishnaswamy, Smita; Spitzer, Matthew H et al. (2014) Single-cell mass cytometry of TCR signaling: amplification of small initial differences results in low ERK activation in NOD mice. Proc Natl Acad Sci U S A 111:16466-71
Hedrick, Stephen M (2012) Positive selection in the thymus: an enigma wrapped in a mystery. J Immunol 188:2043-5
Chang, Chiung-Fang; D'Souza, Warren N; Ch'en, Irene L et al. (2012) Polar opposites: Erk direction of CD4 T cell subsets. J Immunol 189:721-31
Gu, Luo; Ruff, Laura E; Qin, Zhengtao et al. (2012) Multivalent porous silicon nanoparticles enhance the immune activation potency of agonistic CD40 antibody. Adv Mater 24:3981-7
Soto, Paula C; Stein, Lance L; Hurtado-Ziola, Nancy et al. (2010) Relative over-reactivity of human versus chimpanzee lymphocytes: implications for the human diseases associated with immune activation. J Immunol 184:4185-95
Hedrick, Stephen M (2009) Immune system: not so superior. Science 325:1623-4
McGargill, Maureen A; Ch'en, Irene L; Katayama, Carol D et al. (2009) Cutting edge: Extracellular signal-related kinase is not required for negative selection of developing T cells. J Immunol 183:4838-42
Fan, Heng-Yu; Liu, Zhilin; Shimada, Masayuki et al. (2009) MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 324:938-41
D'Souza, Warren N; Chang, Chiung-Fang; Fischer, April M et al. (2008) The Erk2 MAPK regulates CD8 T cell proliferation and survival. J Immunol 181:7617-29
McGargill, Maureen A; Sharp, Leslie L; Bui, Jack D et al. (2005) Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling. J Immunol 175:656-64

Showing the most recent 10 out of 44 publications